Article | August 31, 2026

Five Hidden Risks In Early-Phase OSD Formulation Development

GettyImages-950086574-oral-solid-OSD-pill-tablet-capsule-development

Formulation decisions made during early-phase OSD development often look sound at the time. The problems tend to emerge later, when scalability demands, stability data, or regulatory review expose gaps that earlier choices left unaddressed. Five recurring risk areas drive a disproportionate share of preventable delays in OSD programs: API complexity, excipient compatibility, scalability assumptions, stability planning, and regulatory readiness. Each represents a point where teams commonly underestimate long-term consequences in the interest of reaching first-in-human milestones.

The article outlines where these risks tend to originate and how development teams can plan more effectively at the outset, before compounding decisions narrow their options. Explore the analysis to identify where your program may be most exposed.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online